Dr Martens has reported a 61.3% increase in adjusted profit before tax for the 52 weeks ended March 29, 2026, as the company continued its shift towards a consumer-first operating model.

Adjusted PBT reached £55 million (€64.4 million), compared to £34.1 million (€39.9 million) a year earlier, while revenue declined 2.9% to £764.9 million (€895.3 million). Adjusted EBIT rose 30.6% to £79.3 million (€92.8 million).

Share this story: